Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma

Stopped early

Conditions studied: Kidney (Renal Cell) Cancer

In brief

Impact on contrast dose or total volume of contrast required to effectively treat the targeted tumor.

Key facts

Study ID

NCT01326390

Run by

Stanford University

People needed

13

Starts

2010-05-01

Expected to finish

2012-01-01

Last updated by the study team

2016-07-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must be affected by HCC
• Patients must have diminished renal function (GFR<60 ml/min/1.73m\^2)
• Patients must be 18 years old or older
• Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to the TACE procedure.
• Ability to understand and the willingness to sign a written informed consent document.

You may not qualify if…

• Subjects under the age of 18
• Patients currently on dialysis
• Pregnant women

Where it is running

• Stanford University School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.